Exelixis, Inc. (EXEL)
64.53
-0.78
(-1.19%)
USD |
NASDAQ |
Oct 23, 16:00
64.56
+0.03
(+0.05%)
After-Hours: 20:00
Exelixis Price : 64.53 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 65.15 | 65.20 | 63.91 | 64.53 | 2.066M |
| Oct 22, 2026 | 64.74 | 65.50 | 64.33 | 65.31 | 1.710M |
| Oct 21, 2026 | 64.12 | 64.78 | 64.11 | 64.58 | 1.494M |
| Oct 20, 2026 | 63.01 | 64.42 | 62.84 | 64.39 | 2.137M |
| Oct 19, 2026 | 61.84 | 62.81 | 61.67 | 62.68 | 1.934M |
| Oct 16, 2026 | 62.98 | 63.39 | 61.74 | 62.23 | 2.638M |
| Oct 15, 2026 | 61.69 | 63.31 | 61.28 | 62.83 | 2.774M |
| Oct 14, 2026 | 59.92 | 61.18 | 59.56 | 60.99 | 2.753M |
| Oct 13, 2026 | 60.00 | 60.00 | 58.59 | 59.51 | 2.625M |
| Oct 12, 2026 | 60.48 | 61.66 | 59.80 | 59.82 | 3.129M |
| Oct 09, 2026 | 59.00 | 60.83 | 59.00 | 59.86 | 2.666M |
| Oct 08, 2026 | 58.07 | 60.08 | 57.91 | 59.02 | 2.685M |
| Oct 07, 2026 | 58.47 | 59.26 | 57.88 | 58.44 | 2.375M |
| Oct 06, 2026 | 58.85 | 59.00 | 57.02 | 58.33 | 2.032M |
| Oct 05, 2026 | 58.36 | 59.79 | 57.82 | 58.85 | 2.581M |
| Oct 02, 2026 | 58.11 | 58.97 | 57.94 | 58.39 | 1.969M |
| Oct 01, 2026 | 58.54 | 59.28 | 57.76 | 57.94 | 1.369M |
| Sep 30, 2026 | 58.90 | 61.14 | 58.40 | 58.41 | 3.065M |
| Sep 29, 2026 | 58.06 | 59.12 | 57.53 | 58.65 | 2.244M |
| Sep 28, 2026 | 57.97 | 58.66 | 57.51 | 58.37 | 1.279M |
| Sep 25, 2026 | 58.25 | 58.62 | 57.63 | 58.16 | 1.990M |
| Sep 24, 2026 | 56.70 | 57.99 | 56.58 | 57.95 | 1.926M |
| Sep 23, 2026 | 58.22 | 58.66 | 56.26 | 56.73 | 1.432M |
| Sep 22, 2026 | 57.65 | 59.09 | 57.33 | 58.15 | 1.860M |
| Sep 21, 2026 | 58.61 | 58.80 | 56.90 | 57.22 | 2.103M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Alnylam Pharmaceuticals, Inc. | 224.03 |
| BioMarin Pharmaceutical, Inc. | 55.95 |
| Cytokinetics, Inc. | 61.23 |
| Emergent BioSolutions, Inc. | 6.23 |
| Gilead Sciences, Inc. | 156.04 |
Price Related Metrics
| PE Ratio | 20.27 |
| PS Ratio | 7.165 |
| PEG Ratio | 0.3846 |
| Price to Book Value | 8.711 |
| Price to Free Cash Flow | 14.89 |
| Earnings Yield | 4.93% |
| Market Cap | 16.06B |
| PEGY Ratio | 0.3846 |
| Operating PE Ratio | 17.59 |
| Normalized PE Ratio | 19.95 |